Trump to Announce New Drug Pricing Deals with Multiple Pharmaceutical Companies
President Trump is expected to announce new voluntary drug pricing deals with nearly a dozen pharmaceutical companies, aimed at reducing medication costs in the U.S. by aligning them with lower prices abroad, which could significantly impact the healthcare sector ahead of the midterm elections.